Cargando…
Leveraging the Structure of DNAJA1 to Discover Novel Potential Pancreatic Cancer Therapies
Pancreatic cancer remains one of the deadliest forms of cancer with a 5-year survival rate of only 11%. Difficult diagnosis and limited treatment options are the major causes of the poor outcome for pancreatic cancer. The human protein DNAJA1 has been proposed as a potential therapeutic target for p...
Autores principales: | Roth, Heidi E., De Lima Leite, Aline, Palermo, Nicolas Y., Powers, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599757/ https://www.ncbi.nlm.nih.gov/pubmed/36291603 http://dx.doi.org/10.3390/biom12101391 |
Ejemplares similares
-
Structure and Function of Human DnaJ Homologue Subfamily
A Member 1 (DNAJA1) and Its Relationship to Pancreatic Cancer
por: Stark, Jaime L., et al.
Publicado: (2014) -
Human Hsp40 proteins, DNAJA1 and DNAJA2, as potential targets of the immune response triggered by bacterial DnaJ in rheumatoid arthritis
por: Kotlarz, Agnieszka, et al.
Publicado: (2013) -
Structural resemblance of the DNAJA-family protein, Tid1, to the DNAJB-family Hsp40
por: Jang, Jinhwa, et al.
Publicado: (2022) -
DNAJA4 Promotes the Replication of the Chinese Giant Salamander Iridovirus
por: Liu, Zijing, et al.
Publicado: (2022) -
Hsp70 and DNAJA2 limit CFTR levels through degradation
por: Kim Chiaw, Patrick, et al.
Publicado: (2019)